Capstone Therapeutics Corp. Business Finance Contracts & Agreements
46 Contracts & Agreements
- Assignment Agreements (1 contract)
- Contribution Agreements (1)
- Credit Agreements (3)
- Escrow Agreements (1)
- Guarantee Agreements (1)
- Loan Agreements (9)
- Note Agreements (11)
- Purchase Agreements (2)
- Registration Rights Agreements (2)
- Stock Agreements (5)
- Warrant Agreements (10)
- Second Amended and Restated Promissory Note Issued by Capstone Holding Corp. to Brookstone Partners Acquisition XXI Corporation, dated November 11, 2024 (Filed With SEC on December 31, 2024)
- Term Note Issued by TotalStone, LLC, Northeast Masonry Distributors, LLC, and TotalStone Properties, LLC to Berkshire Bank, dated November 22, 2021 (Filed With SEC on December 31, 2024)
- Second Amended and Restated Revolving Credit Note Issued by TotalStone, LLC and Northeast Masonry Distributors, LLC to Berkshire Bank, dated November 14, 2019 (Filed With SEC on December 31, 2024)
- Amendments to Revolving Credit, Term Loan and Security Agreement Still in Effect As of December 30, 2024 (Filed With SEC on December 31, 2024)
- Revolving Credit, Term Loan and Security Agreement by and among TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Berkshire Bank, dated... (Filed With SEC on December 31, 2024)
- Second Amended and Restated Promissory Note, dated November 11, 2024, issued by Capstone Holding Corp. to BP Peptides, LLC (Filed With SEC on December 31, 2024)
- Limited Payment Guarantee dated March 31, 2021, between Capstone Therapeutics Corp. and Brookstone Acquisition Partners XXI Corporation (Filed With SEC on December 31, 2024)
- Non-negotiable Secured Subordinated Contingent Value Promissory Note by and between NEM Purchaser, LLC and Northeast Masonry Distributors, LLC (Filed With SEC on December 31, 2024)
- Non-negotiable Secured Subordinated Promissory Note by and between TotalStone, LLC and Northeast Masonry Distributors, LLC (Filed With SEC on December 31, 2024)
- Consent, Waiver and Amendment to Second Amended and Restated Credit Agreement, dated October 18, 2024, by and between TotalStone, LLC, Northeast Masonry Distributors, LLC,... (Filed With SEC on December 31, 2024)
- Second Amended and Restated Credit Agreement, dated March 8, 2023, by and between TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Stream... (Filed With SEC on December 31, 2024)
- Termination of Securities Purchase, Loan and Security Agreement, dated November 13, 2024, by and between Capstone Holding Corp. and BP Peptides, LLC (Filed With SEC on December 31, 2024)
- Fourth Amendment to Securities Purchase Loan and Security Agreement dated March 15, 2021, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC (Filed With SEC on December 31, 2024)
- Third Amendment to Securities Purchase Loan and Security Agreement dated March 27, 2020, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC (Filed With SEC on December 31, 2024)
- Amended and Restated Warrant to Purchase Common Stock, dated March 20, 2020, issued to BP Peptides, LLC (Filed With SEC on December 31, 2024)
- Third Amendment to the Securities Purchase, Loan and Securities Agreement Dated as of August 23, 2019 (Filed With SEC on August 26, 2019)
- Second Amendment to Securities Purchase, Loan and Security Agreement dated March 15, 2019, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC (Filed With SEC on March 19, 2019)
- Warrant to Purchase Common Stock dated January 30, 2018 (Filed With SEC on February 1, 2018)
- First Amendment to Securities Purchase Loan and Security Agreement dated January 30, 2018, by and between Capstone Therapeutics, Corp. and BP Peptides, LLC (Filed With SEC on February 1, 2018)
- JOINDER AND COUNTERPART SIGNATURE PAGE OF REGISTRATION RIGHTS AGREEMENT OF LIPIMETIX DEVELOPMENT, INC. (Filed With SEC on August 14, 2017)
- SERIES B-2 PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on August 14, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 17, 2017)
- PROMISSORY NOTE (Filed With SEC on July 17, 2017)
- SECURITIES PURCHASE, LOAN AND SECURITY AGREEMENT (Filed With SEC on July 17, 2017)
- Exhibit 10.4 -Series B Preferred Stock and Warrant PurchaseAgreement - Exhibit F – Form of Registration Rights Agreement REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 26, 2016)
- Exhibit 10.3 – Series B Preferred Stock and Warrant PurchaseAgreement - Exhibit C – Form of Amended and Restated Certificate of Incorporation of LipimetiX Development, Inc.... (Filed With SEC on August 26, 2016)
- LIPIMETIX DEVELOPMENT, INC. WARRANT TO PURCHASE SERIES B-1 PREFERRED STOCK (Filed With SEC on August 26, 2016)
- LIPIMETIX DEVELOPMENT, INC. SERIES B PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on August 26, 2016)
- EXHIBIT A CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 15, 2015)
- EXHIBIT A CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 15, 2015)
- EXHIBIT A CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 15, 2015)
- EXHIBIT A CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 15, 2015)
- EXHIBIT A CONVERTIBLE PROMISSORY NOTE (Filed With SEC on December 15, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 15, 2015)
- COMMON STOCK PURCHASE WARRANT CAPSTONE THERAPEUTICS CORP. (Filed With SEC on September 16, 2015)
- ESCROW AGREEMENT (Filed With SEC on August 10, 2012)
- CONTRIBUTION AGREEMENT (Filed With SEC on August 10, 2012)
- Amended and Restated Class D Warrant Agreement dated February 24, 2006, and amended and restated as of June 30, 2006, related to the Common Stock and Warrant Purchase Agreement by... (Filed With SEC on March 5, 2008)
- Amended and Restated Class C Warrant Agreement related to the Common Stock and Warrant Purchase Agreement by and between OrthoLogic Corp. and PharmaBio Development, Inc (Filed With SEC on May 7, 2007)
- Purchase Agreement dated March 6, 2007 by and between the Company and Presson Advisory, LLC (Filed With SEC on March 9, 2007)